MET-dependent solid tumours - molecular diagnosis and targeted therapy

作者: Robin Guo , Jia Luo , Jason Chang , Natasha Rekhtman , Maria Arcila

DOI: 10.1038/S41571-020-0377-Z

关键词:

摘要: … Thankfully, the field of MET-directed targeted therapy has seen incremental gains over the … tumours of this phenotype in prospective trials investigating the efficacy of targeted therapies. …

参考文章(240)
Gromoslaw A. Smolen, Raffaella Sordella, Beth Muir, Gayatry Mohapatra, Anne Barmettler, Heidi Archibald, Woo J. Kim, Ross A. Okimoto, Daphne W. Bell, Dennis C. Sgroi, James G. Christensen, Jeffrey Settleman, Daniel A. Haber, Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752 Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 2316- 2321 ,(2006) , 10.1073/PNAS.0508776103
Travis I Zack, Steven E Schumacher, Scott L Carter, Andrew D Cherniack, Gordon Saksena, Barbara Tabak, Michael S Lawrence, Cheng-Zhong Zhang, Jeremiah Wala, Craig H Mermel, Carrie Sougnez, Stacey B Gabriel, Bryan Hernandez, Hui Shen, Peter W Laird, Gad Getz, Matthew Meyerson, Rameen Beroukhim, Pan-cancer patterns of somatic copy number alteration Nature Genetics. ,vol. 45, pp. 1134- 1140 ,(2013) , 10.1038/NG.2760
Laura Schmidt, Fuh-Mei Duh, Fan Chen, Takeshi Kishida, Gladys Glenn, Peter Choyke, Stephen W. Scherer, Zhenping Zhuang, Irina Lubensky, Michael Dean, Rando Allikmets, Abi Chidambaram, Ulf R. Bergerheim, J. Timothy Feltis, Carme Casadevall, Agustin Zamarron, Marta Bernues, Stephane Richard, C.J.M. Lips, McClellan M. Walther, Lap-Chee Tsui, Laura Geil, Mary Lou Orcutt, Thomas Stackhouse, Jami Lipan, Leah Slife, Hiltrud Brauch, Jochen Decker, Gloria Niehans, Michael D. Hughson, Holger Moch, Stephan Storkel, Michael I. Lerman, W. Marston Linehan, Berton Zbar, Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas Nature Genetics. ,vol. 16, pp. 68- 73 ,(1997) , 10.1038/NG0597-68
M. Jeffers, L. Schmidt, N. Nakaigawa, C. P. Webb, G. Weirich, T. Kishida, B. Zbar, G. F. Vande Woude, Activating mutations for the Met tyrosine kinase receptor in human cancer Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 11445- 11450 ,(1997) , 10.1073/PNAS.94.21.11445
Heounjeong Go, Yoon Kyung Jeon, Hyo Jin Park, Sook-Whan Sung, Jeong-Wook Seo, Doo Hyun Chung, High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer. Journal of Thoracic Oncology. ,vol. 5, pp. 305- 313 ,(2010) , 10.1097/JTO.0B013E3181CE3D1D
Barbara Sennino, Toshina Ishiguro-Oonuma, Brian J. Schriver, James G. Christensen, Donald M. McDonald, Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic mice. Cancer Research. ,vol. 73, pp. 3692- 3703 ,(2013) , 10.1158/0008-5472.CAN-12-2160
Pascal Peschard, Tanya M Fournier, Louie Lamorte, Monica A Naujokas, Hamid Band, Wallace Y Langdon, Morag Park, Mutation of the c-Cbl TKB Domain Binding Site on the Met Receptor Tyrosine Kinase Converts It into a Transforming Protein Molecular Cell. ,vol. 8, pp. 995- 1004 ,(2001) , 10.1016/S1097-2765(01)00378-1
Alexandra Voutsina, Maria Tzardi, Aristea Kalikaki, Zafeiris Zafeiriou, Elsa Papadimitraki, Michael Papadakis, Dimitris Mavroudis, Vassilis Georgoulias, Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer. Modern Pathology. ,vol. 26, pp. 302- 313 ,(2013) , 10.1038/MODPATHOL.2012.150
Kouichiro Tsugawa, Yutaka Yonemura, Yasuo Hirono, Sachio Fushida, Masahide Kaji, Kouichi Miwa, Itsuo Miyazaki, Hiroshi Yamamoto, Amplification of the c-met, c-erbB-2 and Epidermal Growth Factor Receptor Gene in Human Gastric Cancers: Correlation to Clinical Features Oncology. ,vol. 55, pp. 475- 481 ,(1998) , 10.1159/000011898
Daniel M Aebersold, Olfert Landt, Sylvie Berthou, Günther Gruber, Karl T Beer, Richard H Greiner, Yitzhak Zimmer, Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx. Oncogene. ,vol. 22, pp. 8519- 8523 ,(2003) , 10.1038/SJ.ONC.1206968